Across a decade of investing, Dolby Family Ventures has built a committed team of venture professionals with deep experience as investors, founders, scientists, and engineers.
Team
We take a long-term approach to major challenges in science and engineering, applying decades of pattern recognition and subject matter expertise in our investing and oversight.
Our SAB is comprised of leading subject matter experts in the fields of Alzheimer’s Disease, psychiatry, and neurotechnology. SAB members provide scientific evaluation of early stage investment opportunities, with a focus on disease modifying therapeutics.
